Shopping Cart 0
Cart Subtotal
USD 0

Baylor Scott & White Health - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
USD 750

Details

Summary

Baylor Scott & White Health (Baylor Scott & White) is a not-for-profit healthcare service provider that offers medical care services. The organization offers medical education, medical services and conducts medical research. It offers medical services in the areas of emergency care, cancer care, behavioral and psychological health, heart health, breast care, body composition analysis, cholesterol, blood pressure, pediatric care and primary care, among others. The organization conducts its research through various institutes and centers. It operates through its hospitals and patient care sites across the US. Baylor Scott & White is headquartered in Dallas, Texas, the US.

Baylor Scott & White Health-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Baylor Scott & White Health, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Baylor Scott & White Health, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Baylor Scott & White Health, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Baylor Scott & White Health, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Baylor Scott & White Health, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Baylor Scott & White Health, Pharmaceuticals & Healthcare, Deal Details 11

Partnerships 11

Baylor Research Enters into Licensing Agreement with Swedish Orphan Biovitrum 11

Baylor Scott & White Health Forms Joint Venture with AccentCare 12

Abzena and Baylor Scott & White Research Institute Form Joint Venture 13

Baylor College of Medicine Enters into Research Agreement with Baylor Scott & White Health 14

TGen Enters into Research Agreement with Baylor Research Institute 15

Antitope Extends Research Agreement with ANRS, INSERM and Baylor Research Institute 16

Roche, ANRS, Baylor Researh Institute And Inserm Transfert Enter Into Co-Development Agreement For Therapeutic Vaccines 17

Licensing Agreements 19

Ultragenyx Pharma Expands Licensing Agreement With Baylor Research Institute For Triheptanoin 19

Baylor Scott & White Health-Key Competitors 21

Baylor Scott & White Health-Key Employees 22

Baylor Scott & White Health-Locations And Subsidiaries 24

Head Office 24

Other Locations & Subsidiaries 24

Recent Developments 25

Strategy And Business Planning 25

Apr 10, 2017: Baylor Scott & White Health Opening Austin-Area Westlake Clinic 25

Mar 30, 2017: Baylor Scott & White Health Convenient Care Clinics to Open across Dallas-Fort Worth Area in Tom Thumb Stores 26

Mar 29, 2017: Baylor Scott & White Health Opening Kyle, Texas, Clinic 27

Feb 22, 2017: Baylor Scott & White Health Opens Cancer Center in College Station 28

Feb 08, 2017: Baylor Scott & White Health Increasing Health and Wellness Options with New Medical Center in Pflugerville 29

Jan 17, 2017: Baylor Scott & White Health Opening Austin-Area Primary Care Clinics, Offering App-Based Care Delivery Downtown 30

Jan 04, 2017: New Retail Pharmacy Opens Inside the Baylor Scott & White Medical Center-College Station 31

Corporate Communications 32

Mar 12, 2018: Baylor Scott And White Medical Center Frisco Announces New CEO 32

Nov 07, 2017: Baylor Scott & White Health Strengthens Executive Leadership Team with New Hire and Promotions 33

Legal and Regulatory 34

Jan 13, 2017: Baylor Scott & White Charles A. Sammons Cancer Center-McKinney Accredited by the Commission on Cancer of the American College of Surgeons 34

Government and Public Interest 35

Mar 29, 2017: Study Identifies Gene Mutation that Boosts Aspirin's Cancer Prevention Benefits 35

Mar 06, 2017: New Colon Cancer Biomarkers May Guide Development of Personalized Treatment 36

Feb 13, 2017: Dallas Researchers Identify How Common Gut Bacteria May Cause Colon Cancer 37

Product News 38

Mar 03, 2017: Baylor Scott White Health Introduces Robotic-Assisted Cardiac Catheterization Technology to DFW 38

Other Significant Developments 39

Mar 22, 2018: Blue Cross and Blue Shield of Texas, Baylor Scott & White Health Announce New Agreement That Will Expand Access to Care 39

Jul 13, 2017: Baylor Scott & White Health Selects Kyruus' Solutions to Enhance Provider Data Management and Patient Access 40

Mar 28, 2017: The Heart Hospital Baylor Plano Performs First Robotic-Assisted Peripheral Intervention in Texas 41

Mar 13, 2017: Baylor Scott & White Cancer Center-College Station Brings Care Where it's Needed Most 42

Appendix 44

Methodology 44

About GlobalData 44

Contact Us 44

Disclaimer 44


List Of Figure

List of Figures

Baylor Scott & White Health, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Baylor Scott & White Health, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Baylor Scott & White Health, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Baylor Scott & White Health, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Baylor Scott & White Health, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Baylor Scott & White Health, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

Baylor Scott & White Health, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Baylor Scott & White Health, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9


List Of Table

List of Tables

Baylor Scott & White Health, Pharmaceuticals & Healthcare, Key Facts 2

Baylor Scott & White Health, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Baylor Scott & White Health, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Baylor Scott & White Health, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Baylor Scott & White Health, Deals By Therapy Area, 2012 to YTD 2018 9

Baylor Scott & White Health, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Baylor Research Enters into Licensing Agreement with Swedish Orphan Biovitrum 11

Baylor Scott & White Health Forms Joint Venture with AccentCare 12

Abzena and Baylor Scott & White Research Institute Form Joint Venture 13

Baylor College of Medicine Enters into Research Agreement with Baylor Scott & White Health 14

TGen Enters into Research Agreement with Baylor Research Institute 15

Antitope Extends Research Agreement with ANRS, INSERM and Baylor Research Institute 16

Roche, ANRS, Baylor Researh Institute And Inserm Transfert Enter Into Co-Development Agreement For Therapeutic Vaccines 17

Ultragenyx Pharma Expands Licensing Agreement With Baylor Research Institute For Triheptanoin 19

Baylor Scott & White Health, Key Competitors 21

Baylor Scott & White Health, Key Employees 22

Baylor Scott & White Health, Subsidiaries 24

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Baylor Scott & White Health, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Company Profile

Company Profile Title

Summary

Baylor Scott & White Health (Baylor Scott & White) is a not-for-profit healthcare service provider that offers medical care services. The organization offers medical education, medical services and conducts medical research. It offers medical services in the areas of emergency care, cancer care, behavioral and psychological health, heart health, breast care, body composition analysis, cholesterol, blood pressure, pediatric care and primary care, among others. The organization conducts its research through various institutes and centers. It operates through its hospitals and patient care sites across the US. Baylor Scott & White is headquartered in Dallas, Texas, the US.

Baylor Scott & White Health-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Baylor Scott & White Health, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Baylor Scott & White Health, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Baylor Scott & White Health, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Baylor Scott & White Health, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Baylor Scott & White Health, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Baylor Scott & White Health, Pharmaceuticals & Healthcare, Deal Details 11

Partnerships 11

Baylor Research Enters into Licensing Agreement with Swedish Orphan Biovitrum 11

Baylor Scott & White Health Forms Joint Venture with AccentCare 12

Abzena and Baylor Scott & White Research Institute Form Joint Venture 13

Baylor College of Medicine Enters into Research Agreement with Baylor Scott & White Health 14

TGen Enters into Research Agreement with Baylor Research Institute 15

Antitope Extends Research Agreement with ANRS, INSERM and Baylor Research Institute 16

Roche, ANRS, Baylor Researh Institute And Inserm Transfert Enter Into Co-Development Agreement For Therapeutic Vaccines 17

Licensing Agreements 19

Ultragenyx Pharma Expands Licensing Agreement With Baylor Research Institute For Triheptanoin 19

Baylor Scott & White Health-Key Competitors 21

Baylor Scott & White Health-Key Employees 22

Baylor Scott & White Health-Locations And Subsidiaries 24

Head Office 24

Other Locations & Subsidiaries 24

Recent Developments 25

Strategy And Business Planning 25

Apr 10, 2017: Baylor Scott & White Health Opening Austin-Area Westlake Clinic 25

Mar 30, 2017: Baylor Scott & White Health Convenient Care Clinics to Open across Dallas-Fort Worth Area in Tom Thumb Stores 26

Mar 29, 2017: Baylor Scott & White Health Opening Kyle, Texas, Clinic 27

Feb 22, 2017: Baylor Scott & White Health Opens Cancer Center in College Station 28

Feb 08, 2017: Baylor Scott & White Health Increasing Health and Wellness Options with New Medical Center in Pflugerville 29

Jan 17, 2017: Baylor Scott & White Health Opening Austin-Area Primary Care Clinics, Offering App-Based Care Delivery Downtown 30

Jan 04, 2017: New Retail Pharmacy Opens Inside the Baylor Scott & White Medical Center-College Station 31

Corporate Communications 32

Mar 12, 2018: Baylor Scott And White Medical Center Frisco Announces New CEO 32

Nov 07, 2017: Baylor Scott & White Health Strengthens Executive Leadership Team with New Hire and Promotions 33

Legal and Regulatory 34

Jan 13, 2017: Baylor Scott & White Charles A. Sammons Cancer Center-McKinney Accredited by the Commission on Cancer of the American College of Surgeons 34

Government and Public Interest 35

Mar 29, 2017: Study Identifies Gene Mutation that Boosts Aspirin's Cancer Prevention Benefits 35

Mar 06, 2017: New Colon Cancer Biomarkers May Guide Development of Personalized Treatment 36

Feb 13, 2017: Dallas Researchers Identify How Common Gut Bacteria May Cause Colon Cancer 37

Product News 38

Mar 03, 2017: Baylor Scott White Health Introduces Robotic-Assisted Cardiac Catheterization Technology to DFW 38

Other Significant Developments 39

Mar 22, 2018: Blue Cross and Blue Shield of Texas, Baylor Scott & White Health Announce New Agreement That Will Expand Access to Care 39

Jul 13, 2017: Baylor Scott & White Health Selects Kyruus' Solutions to Enhance Provider Data Management and Patient Access 40

Mar 28, 2017: The Heart Hospital Baylor Plano Performs First Robotic-Assisted Peripheral Intervention in Texas 41

Mar 13, 2017: Baylor Scott & White Cancer Center-College Station Brings Care Where it's Needed Most 42

Appendix 44

Methodology 44

About GlobalData 44

Contact Us 44

Disclaimer 44


List Of Figure

List of Figures

Baylor Scott & White Health, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Baylor Scott & White Health, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Baylor Scott & White Health, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Baylor Scott & White Health, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Baylor Scott & White Health, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Baylor Scott & White Health, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

Baylor Scott & White Health, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Baylor Scott & White Health, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9


List Of Table

List of Tables

Baylor Scott & White Health, Pharmaceuticals & Healthcare, Key Facts 2

Baylor Scott & White Health, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Baylor Scott & White Health, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Baylor Scott & White Health, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Baylor Scott & White Health, Deals By Therapy Area, 2012 to YTD 2018 9

Baylor Scott & White Health, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Baylor Research Enters into Licensing Agreement with Swedish Orphan Biovitrum 11

Baylor Scott & White Health Forms Joint Venture with AccentCare 12

Abzena and Baylor Scott & White Research Institute Form Joint Venture 13

Baylor College of Medicine Enters into Research Agreement with Baylor Scott & White Health 14

TGen Enters into Research Agreement with Baylor Research Institute 15

Antitope Extends Research Agreement with ANRS, INSERM and Baylor Research Institute 16

Roche, ANRS, Baylor Researh Institute And Inserm Transfert Enter Into Co-Development Agreement For Therapeutic Vaccines 17

Ultragenyx Pharma Expands Licensing Agreement With Baylor Research Institute For Triheptanoin 19

Baylor Scott & White Health, Key Competitors 21

Baylor Scott & White Health, Key Employees 22

Baylor Scott & White Health, Subsidiaries 24

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Baylor Scott & White Health, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.